Equities

Boule Diagnostics AB

Boule Diagnostics AB

Actions
  • Price (EUR)0.55
  • Today's Change-0.042 / -7.09%
  • Shares traded0.00
  • 1 Year change-30.99%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments379738
Total Receivables, Net168156140
Total Inventory627559
Prepaid expenses12115.51
Other current assets, total--0.000.00
Total current assets280338242
Property, plant & equipment, net445947
Goodwill, net858879
Intangibles, net294225163
Long term investments3.243.823.83
Note receivable - long term494637
Other long term assets--0.000.00
Total assets755760572
LIABILITIES
Accounts payable363341
Accrued expenses444140
Notes payable/short-term debt000
Current portion long-term debt/capital leases97105105
Other current liabilities, total262226
Total current liabilities203201211
Total long term debt698551
Total debt166190155
Deferred income tax4.878.3911
Minority interest------
Other liabilities, total3.443.133.90
Total liabilities280297276
SHAREHOLDERS EQUITY
Common stock9.719.714.85
Additional paid-in capital336337202
Retained earnings (accumulated deficit)997472
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total314217
Total equity475463296
Total liabilities & shareholders' equity755760572
Total common shares outstanding393927
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.